Palatin Technologies Inc (PTN) - Total Liabilities

Latest as of March 2025: $10.12 Million USD

Based on the latest financial reports, Palatin Technologies Inc (PTN) has total liabilities worth $10.12 Million USD as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Palatin Technologies Inc - Total Liabilities Trend (1996–2024)

This chart illustrates how Palatin Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Palatin Technologies Inc to evaluate short-term liquidity relative to the company's equity base.

Palatin Technologies Inc Competitors by Total Liabilities

The table below lists competitors of Palatin Technologies Inc ranked by their total liabilities.

Company Country Total Liabilities
Cullen Resources Ltd
AU:CUL
Australia AU$174.32K
Flexituff Ventures International Limited
NSE:FLEXITUFF
India Rs4.67 Billion
Tullow Oil PLC
LSE:TLW
UK GBX3.53 Billion
Shrenik Limited
NSE:SHRENIK
India Rs1.82 Billion
MQ Technology Bhd
KLSE:0070
Malaysia RM18.43 Million
Sherborne Investors Guernsey C Ltd
LSE:SIGC
UK GBX38.06K
Kumho Industrial Co Ltd
KO:002995
Korea ₩1.28 Trillion
iOThree Limited Ordinary Shares
NASDAQ:IOTR
USA $4.88 Million

Liability Composition Analysis (1996–2024)

This chart breaks down Palatin Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Palatin Technologies Inc (PTN) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.32 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.58 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 2.71 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Palatin Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Palatin Technologies Inc (1996–2024)

The table below shows the annual total liabilities of Palatin Technologies Inc from 1996 to 2024.

Year Total Liabilities Change
2024-06-30 $10.85 Million -39.04%
2023-06-30 $17.81 Million -10.09%
2022-06-30 $19.80 Million +12.23%
2021-06-30 $17.65 Million +261.52%
2020-06-30 $4.88 Million +16.60%
2019-06-30 $4.19 Million -65.27%
2018-06-30 $12.05 Million -80.56%
2017-06-30 $62.00 Million +116.49%
2016-06-30 $28.64 Million +65.82%
2015-06-30 $17.27 Million +523.41%
2014-06-30 $2.77 Million +32.18%
2013-06-30 $2.10 Million -40.96%
2012-06-30 $3.55 Million +19.07%
2011-06-30 $2.98 Million -2.92%
2010-06-30 $3.07 Million -68.94%
2009-06-30 $9.89 Million -21.37%
2008-06-30 $12.57 Million -48.15%
2007-06-30 $24.25 Million +11.50%
2006-06-30 $21.75 Million -16.17%
2005-06-30 $25.94 Million +419.61%
2004-06-30 $4.99 Million +22.83%
2003-06-30 $4.06 Million +10.71%
2002-06-30 $3.67 Million +57.67%
2001-06-30 $2.33 Million +17.59%
2000-06-30 $1.98 Million -54.99%
1999-06-30 $4.40 Million +41.94%
1998-06-30 $3.10 Million -27.91%
1997-06-30 $4.30 Million +2.31%
1996-06-30 $4.20 Million --

About Palatin Technologies Inc

NYSE MKT:PTN USA Biotechnology
Market Cap
$598.13 Million
Market Cap Rank
#29745 Global
#5996 in USA
Share Price
$23.00
Change (1 day)
+4.59%
52-Week Range
$17.10 - $23.00
All Time High
$41.00
About

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is… Read more